Marketwire (Wed, 8:00AM)
Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
-
Marketwire (Fri, 7:00AM)
-
Marketwire (May 1, 2013)
-
Marketwire (Apr 22, 2013)
-
Marketwire (Mar 12, 2013)
-
Marketwire (Feb 27, 2013)
-
Marketwire (Feb 26, 2013)
-
Marketwire (Feb 22, 2013)
-
Marketwire (Feb 21, 2013)
-
Marketwire (Feb 20, 2013)
-
Marketwire (Feb 13, 2013)
-
Insiders Love These 10 Outperforming Healthcare StocksKapitall • Tue, Jul 10, 2012
-
3 Outperforming Stocks Under $5 Being Snapped Up By InsidersKapitall • Thu, Jun 14, 2012
-
3 Rallying Stocks Under $5 Being Bought Up By Hedge FundsKapitall • Tue, May 15, 2012
-
3 Rallying Small Caps Selling For Under $5 Being Bought Up By InsidersKapitall • Tue, May 1, 2012
-
20 Micro-Cap Stocks Being Snapped Up By Hedge FundsKapitall • Thu, Dec 15, 2011
-
Marketwire (Wed, 8:00AM)
-
Marketwire (Fri, 7:00AM)
-
Marketwire (May 1, 2013)
-
Marketwire (Apr 22, 2013)
-
Marketwire (Mar 12, 2013)
-
Marketwire (Feb 27, 2013)
-
Marketwire (Feb 26, 2013)
-
Marketwire (Feb 22, 2013)
-
Marketwire (Feb 21, 2013)
-
Marketwire (Feb 20, 2013)
-
Marketwire (Feb 13, 2013)
-
at MarketWatch.com (Feb 8, 2013)
-
Marketwire (Nov 19, 2012)
-
Marketwire (Nov 15, 2012)
-
Marketwire (Nov 6, 2012)
-
Marketwire (Oct 24, 2012)
-
Marketwire (Oct 17, 2012)
ETRM vs. ETF Alternatives
Company Description
We are a development stage medical device company focused on the design and development of devices that use neuroblocking technology to treat obesity, its associated co-morbidities, and other gastrointestinal disorders. Our proprietary neuroblocking technology, which we refer to as VBLOC... More





